Application

18128117 · MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS

Filed 2023-03-29 · Abandoned The official file ↗ · Art unit 1624 · Examiner Rilla Marie Samsell Typical · CPC C07D 403/04 · Prelude Therapeutics Incorporated · BakerHostetler

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

16.6 mo

to disposition 24.0 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.